Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral repair membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etchant, dental pit and fissure sealant, light-curing composite… Read more
Yantai Zhenghai Bio-Tech Co Ltd (300653) - Total Assets
Latest total assets as of September 2025: CN¥964.85 Million CNY
Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) holds total assets worth CN¥964.85 Million CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Yantai Zhenghai Bio-Tech Co Ltd - Total Assets Trend (2012–2024)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Yantai Zhenghai Bio-Tech Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Yantai Zhenghai Bio-Tech Co Ltd's total assets of CN¥964.85 Million consist of 72.7% current assets and 27.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.9% |
| Accounts Receivable | CN¥51.41 Million | 5.3% |
| Inventory | CN¥35.18 Million | 3.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥32.53 Million | 3.3% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yantai Zhenghai Bio-Tech Co Ltd's current assets represent 72.7% of total assets in 2024, an increase from 63.7% in 2012.
- Cash Position: Cash and equivalents constituted 11.9% of total assets in 2024, down from 33.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 6.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 5.3% of total assets.
Yantai Zhenghai Bio-Tech Co Ltd Competitors by Total Assets
Key competitors of Yantai Zhenghai Bio-Tech Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Yantai Zhenghai Bio-Tech Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Yantai Zhenghai Bio-Tech Co Ltd generates 0.37x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Yantai Zhenghai Bio-Tech Co Ltd generates $ 13.74 in net profit.
Yantai Zhenghai Bio-Tech Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.89 | 9.93 | 3.64 |
| Quick Ratio | 8.52 | 9.44 | 3.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥632.08 Million | CN¥ 637.30 Million | CN¥ 382.13 Million |
Yantai Zhenghai Bio-Tech Co Ltd - Advanced Valuation Insights
This section examines the relationship between Yantai Zhenghai Bio-Tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.22 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | -7.0% |
| Total Assets | CN¥980.11 Million |
| Market Capitalization | $269.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values Yantai Zhenghai Bio-Tech Co Ltd's assets below their book value (0.28 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Yantai Zhenghai Bio-Tech Co Ltd's assets decreased by 7.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Yantai Zhenghai Bio-Tech Co Ltd (2012–2024)
The table below shows the annual total assets of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥980.11 Million | -6.99% |
| 2023-12-31 | CN¥1.05 Billion | +6.78% |
| 2022-12-31 | CN¥986.90 Million | +6.24% |
| 2021-12-31 | CN¥928.92 Million | +15.32% |
| 2020-12-31 | CN¥805.54 Million | +11.81% |
| 2019-12-31 | CN¥720.45 Million | +23.37% |
| 2018-12-31 | CN¥583.98 Million | +10.02% |
| 2017-12-31 | CN¥530.82 Million | +104.84% |
| 2016-12-31 | CN¥259.14 Million | +29.34% |
| 2015-12-31 | CN¥200.35 Million | +143.41% |
| 2014-12-31 | CN¥82.31 Million | +5.81% |
| 2013-12-31 | CN¥77.79 Million | -15.24% |
| 2012-12-31 | CN¥91.78 Million | -- |